KARYOPHARM THERAPEUTICS INC
(48576U106)
ファンドの報告 KARYOPHARM THERAPEUTICS INC 13F提出書類による
| 商号 | 保有株式/元本 | 市場価格 | オプション | 報告期間 | 有効日 |
|---|---|---|---|---|---|
| Consonance Capital Management LP | 5,803,227 | $34,761k | Jun 30, 2019 | Aug 14, 2019 | |
| PALO ALTO Investors LP | 5,262,263 | $31,521k | Jun 30, 2019 | Aug 14, 2019 | |
| Orbimed Advisors LLC | 3,148,475 | $18,859k | Jun 30, 2019 | Aug 14, 2019 | |
| Point72 Asset Management LP | 2,596,323 | $15,552k | Jun 30, 2019 | Aug 14, 2019 | |
| Emerald Mutual Fund Advisers Trust | 1,375,399 | $8,239k | Jun 30, 2019 | Jul 31, 2019 | |
| Spark Investment Management LLC | 86,951 | $520k | Jun 30, 2019 | Aug 12, 2019 | |
| Premier Asset Management LLC | 26,742 | $160k | Jun 30, 2019 | Aug 7, 2019 | |
| Prelude Capital Management LLC | 1,524 | $9k | Jun 30, 2019 | Aug 14, 2019 |